Investors

Corporate governance

This information was last updated .

The Board is committed to the principles of good corporate governance and believes that an effective corporate governance framework is essential to underpin the success of the Group’s business. The Board is committed to achieving the highest standards of integrity, ethics, professionalism and business practice throughout the Group’s operations. Therefore, the Company has adopted the Quoted Companies Alliance Corporate Governance Code (the “QCA Code”), in line with the AIM Rules for Companies, which requires all AIM-quoted companies to adopt a recognised corporate governance code and to explain how the company complies with and where it departs from the chosen code. Click here for details and refer to page 18 onwards of the 2025 Annual Report.

Graham Cooley (Chairman) – 24th April 2026

Board members responsibilities

The Board is responsible for the overall management of the Group. The Board will meet at least 6 times a year and otherwise on an as-required basis, to review, formulate and approve the Group’s strategy, budgets, corporate actions and oversee the Group’s progress towards its goals.

The key procedures which the Board has established with a view to providing effective internal financial control include the following:

– the Company has instituted a monthly management reporting process to enable the Board to monitor the performance of the Company;

– the Board has adopted and reviewed a comprehensive annual budget for the Company. Monthly results will be examined against the budget and deviations will be closely monitored by the Board; and

– the Board is responsible for maintaining and identifying major business risks faced by the Company and for determining the appropriate courses of action to manage those risks.

The Company has established an Audit and Risk Committee, a Remuneration Committee, and a Nomination Committee, each with formally delegated duties and responsibilities and with written terms of reference. From time to time, separate committees may be set up by the Board to consider specific issues when the need arises.

There is a clear separation of the roles of Chairman and Chief Executive Officer.

The Chairman is responsible for the running of the Board and has ultimate responsibility for corporate governance matters. With guidance from the Company’s advisers, the Chairman will assess the appropriateness of the Company’s governance structures as the Group continues to develop. The Company is committed to the evolution of its corporate governance in line with best practice, and following recent updates to the QCA Code has or intends to implement a variety of minor amendments to current practices, including enhancement to the risk management and sustainability activities, and implementing a more formal board effectiveness review and succession planning process

The Chief Executive Officer is ultimately responsible for the day-to-day running of the business and implementing the Board’s strategy and decisions.

Board Effectiveness Review and Succession planning

The Board intends to review its performance within the coming months and annually thereafter by conducting a self-review questionnaire covering a variety of areas, including the skills the Board possesses; the effectiveness with which the committees carry out their duties; and other aspects of the governance processes and structure. The Company’s financial performance, stakeholder feedback, and other sources of information are also used in the evaluation. This has evolved from the prior year where reviews were more informal in nature. The Board considers an externally facilitated review to be a valuable tool for driving continuous improvement and will supplement its internal review process in the coming years with an externally facilitated review, as the size and nature of the Group develops.

The results and planned actions will be reviewed and agreed when the nomination committee meets later in the year, this review will coincide with consideration of the Company’s succession planning for board and divisional leadership appointments

Stakeholder feedback

The Board recognises the importance of corporate social responsibility as critical to the Group’s long-term success and seeks continued engagement with the Company’s stakeholders, through direct contact by the executive or senior management team feedback from key stakeholders is obtained

Given the size and early stage of the Agtech and Passive Fire Protection divisions’ operations, the Board is very familiar with the Group’s operations as well as the industries, enabling the Board to clearly identify key resources and relationships on which the Group relies, this includes employees, customers and suppliers. As a result of feedback from such stakeholders, actions have been taken to improve service levels and integrate into the innovative products in development.

The Chief Financial Officer will be the primary contact for shareholders and there is a dedicated e-mail address for shareholder questions and comments shareholders@lightsciencetech.com.

Audit and Risk Committee

The audit and risk committee comprises Richard Mills and Graham Cooley, and is chaired by Richard Mills.

The audit and risk committee is responsible for monitoring the integrity of the Company’s financial statements, reviewing significant financial reporting issues, reviewing the effectiveness of the Company’s internal control and risk management systems, monitoring the need for and if necessary the effectiveness of the internal audit function and overseeing the relationship with the external auditors including advising on their appointment, agreeing the scope of the audit and reviewing the audit findings.

The audit committee meets at least three times a year at appropriate times in the reporting and audit cycle and otherwise as required. The audit committee meets regularly with the Company’s external auditors.

Remuneration Committee

The remuneration committee is comprised of Richard Mills and Graham Cooley, and is chaired by Richard Mills.

The remuneration committee is responsible for determining and agreeing with the Board the policy for the remuneration of the Chief Executive Officer, the other executive Directors and other designated senior executives and, within the terms of the agreed policy, determining the total individual remuneration packages of such persons including, where appropriate, bonuses, incentive payments and share options or other share awards.

The remuneration of non-executive Directors is a matter for the executive members of the Board. No Director is involved in any decision as to his or her own remuneration. The remuneration committee meets at least twice a year and otherwise as required.

Nominations Committee

The nominations committee is comprised of Graham Cooley, Richard Mills and Andrew Hempsall, and is chaired by Graham Cooley.

The nominations committee is responsible for reviewing the structure, size and composition of the Board and identifying and nominating, for the approval of Board, candidates to fill vacancies on the Board as and when they arise. The nominations committee meets at least twice a year and otherwise as required.

For Media or Investor Relations Enquiries

Walbrook PR Limited

+44 (0) 20 7933 8780
lst@walbrookpr.com

Disclaimer

The information contained in these slides and this presentation is being supplied to you by Light Science Technologies Holdings plc (the “Company”) solely for your information. For the purposes of this disclaimer references to the “Presentation” shall mean and include the slides that follow, any video recording or oral briefing in connection with the slides, any question-and-answer session(s) that follow(s) the oral presentation, hard or soft copies of this document and any materials distributed at, or in connection with the Presentation.

This Presentation may not be published, distributed, copied, reproduced, in whole or in part, or otherwise disseminated, directly or indirectly, to the press or any other person. Failure to comply with this restriction may, inter alia, constitute a violation of applicable securities laws.

The content of this Presentation has not been approved by an authorised person within the meaning of the Financial Services and Markets Act 2000 (“FSMA”).

This Presentation does not constitute or form part of any offer or invitation to sell or issue, or any solicitation of any offer to purchase or subscribe for, any securities of the Company nor shall it or any part of it nor the fact of its distribution form the basis of, or be relied on in connection with, any contract, commitment or investment decision in relation to any such matter nor does it constitute a recommendation regarding the securities of the Company. Investors and prospective investors in securities of the Company are required to make their own independent investigation and appraisal of the business and financial condition of the Company and the nature of the securities. This Presentation should not be considered as the giving of investment advice by the Company or any of its shareholders, directors, officers, agents, employees or advisers. Each party to whom this Presentation is made available must make its own independent assessment of the Company after making such investigations and taking such advice as may be deemed necessary. In particular, any estimates or projections or opinions contained herein necessarily involve significant elements of subjective judgment, analysis and assumptions and each recipient should satisfy itself in relation to such matters.

This Presentation is for distribution in the United Kingdom only to persons who are (1) authorised or exempt persons within the meaning of FSMA: or (2) persons who have professional experience in matters relating to investments falling within Article 19(5) and/or Article 49 of the Financial Services and Markets Act 2000 (Financial Promotion) Order 2005; or (3) “qualified investors” within the meaning of Article 2(e) of the Prospectus Regulation (Regulation (EU) 2017/1129) as amended, as it forms part of domestic law by virtue of the European Union (Withdrawal) Act 2018; or (4) persons who are otherwise permitted by law to receive it (collectively referred to as “relevant persons”). The Presentation and any accompanying materials are directed only at relevant persons. Other persons should not act or rely on this Presentation or any of its contents.

The shares of the Company have not been, and will not be, registered under the United States Securities Act of 1933, as amended (the “US Securities Act”), or under the applicable securities law or with any securities regulatory authority of any state or jurisdiction of the United States, and may not be offered or sold, resold, transferred or delivered, directly or indirectly, in the United States or to, or for the account or benefit of, US Persons (as defined in Regulation S under the US Securities Act), except pursuant to an exemption from, or a transaction not subject to, the registration requirements of the US Securities Act.

Neither this Presentation nor any part or copy of it may be taken, transmitted or distributed, directly or indirectly, by any means (including electronic transmission) in or into: (a) the United States, its territories or possessions or to any US Person (“United States”); or (b) Canada, Australia, New Zealand, the Republic of South Africa or Japan, (“together with the United States, being a “Restricted Territory”); or (c) distributed to any individual outside a Restricted Territory who is a citizen, national or resident thereof, or to any corporation, partnership or other entity created or organised under the laws of those. Any such transmission or distribution could result in a violation of relevant securities laws of such jurisdictions.

This Presentation may include certain forward-looking statements, beliefs or opinions relating to the Company and its subsidiaries or proposed subsidiaries (the “Group”), including statements with respect to the Group’s business, financial condition and results of operations. These statements also relate to the future prospects, developments and business strategies of the Company and its Group. These statements, which contain words such as “anticipate”, “believe”, “intend”, “estimate”, “expect”, “forecast”, “could”, “may”, “plan”, “predict”, “project”, “will” or the negative of those variations and words of similar meaning are contained in all sections of the Presentation and reflect the Directors’ beliefs and expectations and involve risk and uncertainty because they relate to events and depend on circumstances that will occur in the future. No representation is made that any of these statements or forecasts will come to pass or that any forecast results will be achieved. There are a number of factors that could cause actual results and developments to differ materially from those expressed or implied by these statements and forecasts. Past performance cannot be relied on as a guide to future performance of the Company or any member of the Group. Forward-looking statements speak only as at the date of this Presentation and the Company expressly disclaims any obligations or undertaking to release any update of, or revisions to, any forward-looking statements in this Presentation. No statement in this Presentation is intended to be a profit forecast. As a result, you are cautioned not to place any undue reliance on such forward-looking statements. This Presentation speaks as of the date hereof.

The contents of this Presentation have not been verified and no reliance may be placed for any purposes whatsoever on the information contained in this document or on its completeness, accuracy or fairness. Any reliance on this Presentation for the purpose of engaging in any investment activity may expose an individual to a significant risk of losing all of the property or other assets invested. The Company, their advisers and each of their respective members, directors, officers and employees are under no obligation to update or keep current the information contained in this Presentation, to correct any inaccuracies which may become apparent, or to publicly announce the result of any revision to the statements made in this document except where they would be required to do so under applicable law, and any opinions expressed in the Presentation are subject to change without notice. None of the Company or any of its subsidiary undertakings or affiliates or directors, officers or any other person (including any of the advisers to the Company) accepts any responsibility whatsoever, nor makes any representation or warranty, express or implied, as to the fairness, accuracy or completeness of the information or opinions contained in this Presentation and no liability whatsoever for any loss howsoever arising from any use of this Presentation or its contents otherwise arising in connection therewith is accepted by any such person in relation to such information. The Company accordingly disclaims all and any responsibility or liability (whether arising in tort, contract or otherwise) which it may otherwise have in respect of this Presentation or its contents.

If the recipient is in any doubt about the contents of this Presentation and any accompanying materials or any action to be taken, the recipient should consult a person authorised for the purposes of FSMA or from another appropriately authorised advisor if they taking advice in a territory outside the United Kingdom.

By attending or viewing the Presentation you agree to be bound by the foregoing limitations and warrant and undertake to the Company that: (i) you are a relevant person and you will observe the foregoing provisions, limitations and conditions; and (ii) you have read, agree to and will comply with the terms of this disclaimer.